EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Biomaterials augmented with filtered bone marrow aspirate for the treatment of talar osteochondral lesions. A comparison of clinical and cellular parameters

Matic Kolar iD, Matija Veber, Lenart Girandon, Matej Drobnič

Journal of Orthopaedic Surgery · 2024-01 · 32 (1)

DOI: 10.1177/10225536231219970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Surgery, online erschienen am 12.01.2024. Verfasst von Matic Kolar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Talus, Cartilage, Articular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biomaterials augmented with Bone Marrow Aspirate Concentrate (BMAC) are becoming increasingly utilized in the cartilage treatment. However, the potential role of cellular parameters in the intraoperatively applied BMAC have yet to be elucidated.

Purpose

(A) To evaluate clinical outcomes and safety of a combined single-step approach with scaffolds (fibrin glues, collagen gels, collagen-hydroxyapatite membrane) and filtered Bone Marrow Aspirate (fBMA) for the treatment of osteochondral lesions of the talus (OLTs). (B) To identify significant factors for postoperative improvements, considering cellular parameters as potential predictors.

Methods

All the patients operated on due to OLTs by the combination above were selected from the hospital registry database (35 pts, years 16–55, and minimally 1 year follow-up). Treatment outcomes were followed clinically with Patient-reported outcome measures (PROMs), and by pursuing serious adverse events (SAE) and graft failures (GF). Cellular parameters of the injected fBMA were determined. Pre- and postoperative PROMs values were compared to evaluate postoperative improvements. Multivariable regression models were applied to identify potential factors (demographics, medical history, joint and lesion characteristics, scaffold type, surgical and cellular parameters) that predict the treatment outcomes.

Results

At the mean follow-up of 32.2 (12.5) months, all Foot and Ankle Outcome Score (FAOS) and European Quality of Life in Five Dimensions Three-Level (EQ-5D-3 L) values improved significantly. 4 (11%) SAE (3 arthrofibrosis, one hardware removal), and 3 (9%) GF occurred. Female gender and concomitant procedures were the main negative predictors for postoperative outcomes. The number of fibroblast colony forming units (CFU-F) or their proportion among total nucleated cells (CFU-F/TNC) were positively correlated with the improvements of some PROMs.

Conclusions

Scaffolds augmented with fBMA proved as an adequate and safe approach for OLTs treatment. Cellular parameters seem to influence the treatment outcomes, thus further attention should be given to the intraoperatively applied products. Level of evidence Level IV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TalusCartilage, ArticularHumansFemaleBone MarrowRetrospective StudiesBiocompatible MaterialsQuality of LifeTreatment OutcomeCollagenMagnetic Resonance ImagingTransplantation, Autologous

Stichwörter der Autor:innen

bone marrow aspiratemesenchymal stem cellsosteochondralscaffoldtalus

Substanzen

Biocompatible MaterialsCollagen

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Chair of Orthopaedics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Educell Ltd, Trzin, Slovenia.

ORCID-Profile: Matic Kolar

Zitieren

APA

Kolar, M., Veber, M., Girandon, L., & Drobnič, M. (2024). Biomaterials augmented with filtered bone marrow aspirate for the treatment of talar osteochondral lesions. A comparison of clinical and cellular parameters. Journal of Orthopaedic Surgery, 32(1). https://doi.org/10.1177/10225536231219970

Vancouver

Kolar M, Veber M, Girandon L, Drobnič M. Biomaterials augmented with filtered bone marrow aspirate for the treatment of talar osteochondral lesions. A comparison of clinical and cellular parameters. Journal of Orthopaedic Surgery. 2024;32(1). doi:10.1177/10225536231219970

BibTeX
@article{Kolar2024,
  author = {Kolar, Matic and Veber, Matija and Girandon, Lenart and Drobnič, Matej},
  title = {Biomaterials augmented with filtered bone marrow aspirate for the treatment of talar osteochondral lesions. A comparison of clinical and cellular parameters},
  journal = {Journal of Orthopaedic Surgery},
  year = {2024},
  volume = {32},
  number = {1},
  doi = {10.1177/10225536231219970}
}
Kostenlos starten →